Skip to main content

Table 1 The number of patients taking concomitant medications during this trial

From: A randomized double blind placebo controlled clinical trial of N-Acetylcysteine added to risperidone for treating autistic disorders

Medication (Mean dose) N-Acetylcysteine+risperidone group (Number) Placebo+risperidone group (Number)
Clonidine (0.75 mg/day) 5 3
Folic acid (1 mg/day) 2 0
Imipramine (10 mg/day) 1 0
Biperiden (2 mg/day) 1 1
Nortriptyline (12.5 mg/day) 1 0
Topiramate (12.5 mg/day) 0 2